$DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study ResultsCall will feature data from DURECT's late-breaking oral presentation at the 2019 Liver Meeting® PR NEWSWIRE 2:47 PM ET 11/6/2019
  • 1
  • 2